Uterine Artery Embolization for the Treatment of Adenomyosis
This review examines adenomyosis pathophysiology, imaging, and recent studies on uterine artery embolization's efficacy for treating this benign uterine disorder.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews adenomyosis as a cause of menorrhagia and dysmenorrhea and discusses its pathophysiology and imaging characteristics, focusing on studies that have evaluated uterine artery embolization as a treatment option. The review notes that adenomyosis was once considered a contraindication to uterine artery embolization, but summarizes “recent studies” assessing efficacy using clinical response and, in several cited works, MR imaging follow-up. A major caveat is that the article is a narrative review rather than a new comparative trial, so the conclusions depend on heterogenous prior reports and do not provide a single consolidated effectiveness estimate. This paper is centrally about adenomyosis — specifically, it reviews uterine artery embolization for treating adenomyosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
6,808 characters
· extracted from
oa-doi-fallback
· 3 sections
· click to expand
Abstract
Keywords
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- Adenomyosis: A reappraisal of symptomatology via openalex
- Adenomyosis in the gravid uterus at term via openalex
- Adenomyosis: MRI of the Uterus Treated with Uterine Artery Embolization via openalex
- Clinical significance of adenomyosis. via openalex
- Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. via openalex
- Embolization for the Treatment of Adenomyosis via openalex
- Failure of uterine fibroid embolization via openalex
- Increased microvessel density in adenomyosis uteri via openalex
- Long-Term Results of Uterine Artery Embolization for Symptomatic Adenomyosis via openalex
- Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis via openalex
- Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis via openalex
- MRI of Adenomyosis: Changes with Uterine Artery Embolization via openalex
- Pathophysiology of adenomyosis via openalex
- Prevalence and risk factors of adenomyosis at hysterectomy via openalex
- The elusive adenomyosis of the uterus via openalex
- Uterine Adenomyosis: Endovaginal US and MR Imaging Features with Histopathologic Correlation via openalex
- Uterine Arterial Embolization With Tris-acryl Gelatin Microspheres via openalex
- Uterine artery embolisation for symptomatic adenomyosis—Mid-term results via openalex
- Uterine Artery Embolization for Adenomyosis: Looking at the Glass Half Full via openalex
- Uterine artery embolization for adenomyosis without fibroids via openalex
- Uterine Artery Embolization for Symptomatic Adenomyosis with or without Uterine Leiomyomas with the Use of Calibrated Tris-acryl Gelatin Microspheres: Midterm Clinical and MR Imaging Follow-up via openalex
- Uterine artery embolization for symptomatic uterine leiomyoma and adenomyosis. via openalex
- W6682900900 via openalex
- W1981661926 via openalex
- W1984528517 via openalex
- W2027874761 via openalex
- W2031932600 via openalex
- W2038950921 via openalex
- W2077955294 via openalex
- W2093448976 via openalex
- W2134068782 via openalex
- W2137329074 via openalex
- W2139349678 via openalex
- W2316234298 via openalex
- W2332760178 via openalex
- W4254116967 via openalex
- W6679524736 via openalex
Cited by (11)
- Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2 2025
- Prevalence, incidence, and treatment trends of adenomyosis in South Korean women for 15 years: A national population-based study 2024
- Novel Minimally Invasive Surgical Approaches to Endometriosis and Adenomyosis: A Comprehensive Review 2024
- Long‐term durability of uterine artery embolisation for treatment of symptomatic adenomyosis 2021
- Successful pregnancy outcome in refractory adenomyosis treated with two sessions of uterine artery embolization: A case report and brief review 2021
- Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis 2021
- Computed Tomography-Guided Superior Hypogastric Plexus Block for Secondary Dysmenorrhea in Perimenopausal Women 2018
- Embolization of uterine and ovarian artery anastomosis in the treatment of menorrhagia secondary to adenomyosis and leiomyoma 2014
- Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases 2013
- Norethindrone Acetate in the Medical Management of Adenomyosis 2012
- Methodological Issues in Preclinical Mouse Efficacy Studies of Adenomyosis 2012
Source provenance
- europepmc
- last seen: 2026-08-18T06:10:16.649438+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:18.065553+00:00